This model can be used to predict the pre-test probability (prior probability) that a person has a BRCA1
or BRCA2 mutation. In general, individuals with at least a 5-10% chance of a mutation are considered good
candidates for genetic testing.
This model does not predict breast cancer risk. It focuses only on the chance that an individual has
inherited a mutation in BRCA1 or BRCA2.